-
Something wrong with this record ?
Long-term myocardial effects of noninvasive ventilation in patients with obesity hypoventilation syndrome
I. Paranicova, S. Bodnarova, I. Trojova, Z. Hertelyova, Z. Gulasova, I. Cimbolakova, S. Genzor, P. Joppa, R. Tkacova, P. Pobeha
Language English Country England, Great Britain
Document type Journal Article
Grant support
APVV-16-0158, AND VEGA 1/0220/17
Slovak Research and Development Agency
1/0393/22
Ministry of Education, Slovakia.
- MeSH
- Biomarkers * blood MeSH
- Time Factors MeSH
- Obesity Hypoventilation Syndrome * therapy physiopathology MeSH
- Interleukin-6 * blood MeSH
- Cardiography, Impedance MeSH
- Middle Aged MeSH
- Humans MeSH
- Natriuretic Peptide, Brain * blood MeSH
- Noninvasive Ventilation * methods MeSH
- Peptide Fragments * blood MeSH
- Aged MeSH
- Tumor Necrosis Factor-alpha blood MeSH
- Troponin I blood MeSH
- Positive-Pressure Respiration methods MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
INTRODUCTION: Chronic effects of noninvasive ventilation on myocardial function in patients with obesity hypoventilation syndrome (OHS) are scarcely understood. The aim of the present study was to evaluate the long-term effects of volume-targeted bilevel positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS. METHODS: Clinically stable patients with OHS referred to the tertiary center for the initiation of long-term BiPAP therapy were consecutively enrolled. At baseline, all participants underwent overnight cardiorespiratory polygraphy. BiPAP therapy using volume-targeted spontaneous/timed mode delivered via an oro-nasal mask was initiated. Beat-to-beat noninvasive monitoring by impedance cardiography was used to assess heart function at baseline and after 3 and 12 months of BiPAP use. Serum troponin 1, N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) were monitored. RESULTS: Thirteen patients (10 men; mean age, 55.8 ± 9.8 years; mean body mass index of 47.8 ± 5.9 kg/m2) were recruited. From baseline to 3, and to 12 months of BiPAP use, left ventricular stroke volume (SV), ejection time (LVET), and ejection time index significantly increased (P = 0.030; P < 0.001; P = 0.003, respectively), while heart rate and systolic time ratio significantly decreased (P = 0.004; P = 0.034, respectively). Reductions in serum NT-proBNP, IL-6 and TNF-α were observed (P = 0.045; P = 0.018; P = 0.003, respectively). No significant changes in serum troponin were detected throughout the study. CONCLUSIONS: The present findings of increased SV, in association with lengthening of LVET, reductions of NT-proBNP and reductions in circulatory inflammatory markers in patients with stable OHS and chronic moderate-to-severe daytime hypercapnia treated with BiPAP over 1 year support the role of this therapeutic mode in such patients.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019117
- 003
- CZ-PrNML
- 005
- 20241024111557.0
- 007
- ta
- 008
- 241015e20240706enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.rmed.2024.107735 $2 doi
- 035 __
- $a (PubMed)38977108
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Paranicova, I $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
- 245 10
- $a Long-term myocardial effects of noninvasive ventilation in patients with obesity hypoventilation syndrome / $c I. Paranicova, S. Bodnarova, I. Trojova, Z. Hertelyova, Z. Gulasova, I. Cimbolakova, S. Genzor, P. Joppa, R. Tkacova, P. Pobeha
- 520 9_
- $a INTRODUCTION: Chronic effects of noninvasive ventilation on myocardial function in patients with obesity hypoventilation syndrome (OHS) are scarcely understood. The aim of the present study was to evaluate the long-term effects of volume-targeted bilevel positive airway pressure ventilation (BiPAP) on cardiac parameters and myocardial biomarkers in patients with OHS. METHODS: Clinically stable patients with OHS referred to the tertiary center for the initiation of long-term BiPAP therapy were consecutively enrolled. At baseline, all participants underwent overnight cardiorespiratory polygraphy. BiPAP therapy using volume-targeted spontaneous/timed mode delivered via an oro-nasal mask was initiated. Beat-to-beat noninvasive monitoring by impedance cardiography was used to assess heart function at baseline and after 3 and 12 months of BiPAP use. Serum troponin 1, N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) were monitored. RESULTS: Thirteen patients (10 men; mean age, 55.8 ± 9.8 years; mean body mass index of 47.8 ± 5.9 kg/m2) were recruited. From baseline to 3, and to 12 months of BiPAP use, left ventricular stroke volume (SV), ejection time (LVET), and ejection time index significantly increased (P = 0.030; P < 0.001; P = 0.003, respectively), while heart rate and systolic time ratio significantly decreased (P = 0.004; P = 0.034, respectively). Reductions in serum NT-proBNP, IL-6 and TNF-α were observed (P = 0.045; P = 0.018; P = 0.003, respectively). No significant changes in serum troponin were detected throughout the study. CONCLUSIONS: The present findings of increased SV, in association with lengthening of LVET, reductions of NT-proBNP and reductions in circulatory inflammatory markers in patients with stable OHS and chronic moderate-to-severe daytime hypercapnia treated with BiPAP over 1 year support the role of this therapeutic mode in such patients.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a hypoventilační syndrom při obezitě $x terapie $x patofyziologie $7 D010845
- 650 12
- $a neinvazivní ventilace $x metody $7 D063087
- 650 12
- $a natriuretický peptid typu B $x krev $7 D020097
- 650 12
- $a biologické markery $x krev $7 D015415
- 650 12
- $a interleukin-6 $x krev $7 D015850
- 650 12
- $a peptidové fragmenty $x krev $7 D010446
- 650 _2
- $a TNF-alfa $x krev $7 D014409
- 650 _2
- $a troponin I $x krev $7 D019210
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a kardiografie impedanční $7 D002307
- 650 _2
- $a ventilace umělá s výdechovým přetlakem $x metody $7 D011175
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bodnarova, S $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
- 700 1_
- $a Trojova, I $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
- 700 1_
- $a Hertelyova, Z $u Center of Clinical and Preclinical Research MEDIPARK, P.J. Safarik University, Faculty of Medicine, Kosice, Slovakia
- 700 1_
- $a Gulasova, Z $u Center of Clinical and Preclinical Research MEDIPARK, P.J. Safarik University, Faculty of Medicine, Kosice, Slovakia
- 700 1_
- $a Cimbolakova, I $u Institute of Physical Education and Sport, P.J. Safarik University, Kosice, Slovakia
- 700 1_
- $a Genzor, S $u Department of Respiratory Medicine and Tuberculosis, University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Joppa, P $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
- 700 1_
- $a Tkacova, R $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia
- 700 1_
- $a Pobeha, P $u Department of Respiratory Medicine and Tuberculosis, P.J. Safarik University, Faculty of Medicine, and L. Pasteur University Hospital, Kosice, Slovakia. Electronic address: pavol.pobeha@upjs.sk
- 773 0_
- $w MED00004105 $t Respiratory medicine $x 1532-3064 $g Roč. 231 (20240706), s. 107735
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38977108 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111551 $b ABA008
- 999 __
- $a ok $b bmc $g 2201752 $s 1231090
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 231 $c - $d 107735 $e 20240706 $i 1532-3064 $m Respiratory medicine $n Respir Med $x MED00004105
- GRA __
- $a APVV-16-0158, AND VEGA 1/0220/17 $p Slovak Research and Development Agency
- GRA __
- $a 1/0393/22 $p Ministry of Education, Slovakia.
- LZP __
- $a Pubmed-20241015